TrialStat Links ESRNexus to ClinicalTrials.gov



As reported in eCliniqua in June, TrialStat at that time was well on its way to building “the world’s largest coded reference database” – the ESRNexus database – with the collaboration of many world-renowned organizations.

In September, the company announced that it had added even more value to the search capabilities of the Web-based ESRNexus database by incorporating the latest clinical trial recruitment postings from the U.S. National Institutes of Health’s ClinicalTrials.gov database – a development that could help increase patient recruitment for those trials.

“We’ve discovered that a large number of the people who use ESRNexus are healthcare consumers researching their own health issues,” says Peter O’Blenis, VP systematic reviews at TrialStat. “They’re checking published literature, but this also lets them see ongoing research in the area. If it’s a condition they’re looking for treatment on, Nexus provides a listing of trials that are recruiting that they may want to take part in. It’s a nice way to get your trials out in front of more people and hopefully aid with the recruiting process.” By drilling down, healthcare consumers can find all the contact information they need to participate in the clinical trial.

Conceived last November, ESRNexus is still in beta development, but O’Blenis says it’s one of the fastest-growing projects he’s been involved with. Since its launch in May, feedback has been coming in from information specialists, librarians and others around the globe. “They’ve been sending us suggestions and helping us to evolve it quickly to meet their needs,” says O’Blenis.

In November, TrialStat will begin offering private accounts on ESRNexus, which will provide users with an additional information asset. “An organization that is conducting health technology assessment or outcomes research – after they’ve done a systematic review in SRS -- can publish all their reference materials and notes into their private accounts,” says O’Blenis. “So whenever they do another systematic review, they will be building on their own internal repository of articles and summarized data.” The private accounts will be in the form of a subscription-based service, as is SRS.

TrialStat also announced that it has completed the integration of ESRNexus with its SRS service. This lets users import articles from ESRNexus into their systematic review and, conversely, share their systematic review protocols and reference articles by publishing them to ESRNexus, if they choose.

---------------------------

Did you find this article informative? Would you like to see more articles like this? Suggest other topics you’d like us to cover.

Click here for a free subscription to eCliniqua.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .